Anxiolytics antagonize yohimbine-induced central noradrenergic activity: A concomitant in vivo voltammetry-electrophysiology model of anxiety

Journal of Neuroscience Methods

Volumn 180, Issue 1, 2009, Pages 97-105

  Crespi, Francesco ^a  

^a GSK   (Italy)

Author keywords

Amygdale; Anxiety model; In vivo voltammetry and electrophysiology; Locus coeruleus; Rat brain; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CATECHOLAMINE; CHLORDIAZEPOXIDE; CLONIDINE; YOHIMBINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; IN VIVO STUDY; MALE; METHODOLOGY; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ADRENERGIC ALPHA-ANTAGONISTS; AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BRAIN; BUSPIRONE; CHLORDIAZEPOXIDE; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; LOCUS COERULEUS; MALE; NEURONS; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NOREPINEPHRINE; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 67349248129     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2009.03.007     Document Type: Article

References (42)

1. Abercrombie E.D., Keller Jr. R.W., and Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27 (1988) 897-904
2. Aghajanian G.K., and VanderMaelen C.P. Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215 (1982) 1394-1396
3. Becker C., Hamon M., and Benoliel J.J. Prevention by 5-HT1A receptor agonists of restraint stress- and YOH-induced release of cholecystokinin in the frontal cortex of the freely moving rat. Neuropharmacology 38 (1999) 525-532
4. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety. 1. Preclinical studies. Synapse 23 (1996) 28-38
5. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety. 2. Clinical studies. Synapse 23 1 (1996) 39-51
6. Broderick P.A. Alprazolam, diazepam, YOH, clonidine: in vivo CA1 hippocampal NA and 5-HT release profiles under chloral hydrate anaesthesia. Prog NeuroPsychopharmacol Biol Psychiatry 21 (1997) 1117-1140
7. Cedarbaum J.M., and Aghajanian G.K. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha antagonist piperoxan. Brain Res 112 (1976) 413-419
8. Cheng C.H., Costall B., Ge J., and Naylor R.J. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br J Pharmacol 110 (1993) 1079-1084
9. Congestri F., Formenti F., Sonntag V., Hdou G., and Crespi F. The selective D3 receptor antagonist SB-277011-A potentiates the effect of cocaine on extracellular dopamine in the nucleus accumbens: a dual core-shell voltammetry study in anesthetized rats. Sensors 8 (2008) 6936-6951
10. Crespi F. In vivo voltammetry with micro-biosensors for analysis of neurotransmitter release and metabolism. J Neurosci Methods 34 (1990) 53-65
11. Crespi F. In vivo voltammetry and concomitant electrophysiology at a single biosensor to analyse ischaemia, depression and drug dependence. J Neurosci Methods 119 (2002) 173-184
12. Crespi, and Jouvet M. Differential pulse voltammetry: parallel peak 3 changes with vigilance states in raphe dorsalis and raphe magnus of chronic freely moving rats and evidence for 5HT contribution to this peak after monoamine oxidase inhibitors. Brain Res 272 (1983) 263-268
13. Crespi F., Sharp T., Maidment N., and Marsden C. Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum using a single carbon fibre electrode. Brain Res 322 (1984) 135-138
14. Crespi F., England T., Ratti E., and Trist D.G. Carbon fibre micro-electrodes for concomitant in vivo electrophysiological and voltammetric measurements: no reciprocal influences. Neurosci Lett 188 (1995) 33-36
15. Crespi F., Martin K.F., and Marsden C.A. Nafion coated carbon fibre electrodes combined with differential pulse voltammetry measure 5-HT release in vivo. Neuroscience 27 (1988) 885-896
16. Dommett E.J., Simpson J., Clark D., and Overton P.G. Identification of an excitatory amino acid-mediated component of the ventral tegmental area local field potential response to medial prefrontal cortex stimulation: effect of acute d-amphetamine. J Neural Transm 114 (2006) 161-172
17. Eison A.S., and Temple Jr. D.L. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80 (1986) 1-9
18. Engberg G., and Eriksson E. Effect of alpha-2 adrenoceptor agonists on locus coeruleus firing rate and brain NA turnover in EEDQ treated rats. Naunyn-Schmiedebergs Arch Pharmacol 343 (1991) 472-477
19. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., and Stewart J. Alpha-2 adrenergic agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23 (2000) 138-141 SO
20. Holmberg G., and Gershon S. Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2 (1961) 93-106
21. Khoshbouei H., Cecchi M., Dove S., Javors M., and Morilak D.A. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71 (2002) 407-417
22. Lang W.J., and Gershon S. Effects of psychoactive drugs on yohimbine-induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents. Arch Int Pharmacodyn Ther 142 (1963) 457-472
23. Le A.D., Harding S., Juzytsch W., Funk D., and Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179 (2005) 366-373
24. Lorez H.P., Kiss D., Da Prada M., and Haeusler G. Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system. Naunyn-Schmiedebergs Arch Pharmacol 323 (1983) 307-314
25. Martin K., Marsden C., and Crespi F. In vivo electrochemistry with carbon fibre electrodes: principles and application to neuropharmacology. Trends Anal Chem 7 (1988) 334-339
26. Meana J.J., Herrera-Marschitz M., Goini M., and Silveira R. Modulation of catecholamine release by alpha-2 adrenoceptors and I1-imidazoline receptors in rat brain. Brain Res 744 (1997) 216-226
27. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23 (1997) 145-195
28. Nevo I., Becker C., Hamon M., and Benoliel J.J. Stress- and YOH-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron. J Neurochem 66 (1996) 2041-2049
29. Nugent F.S., Hwong A.R., Udaka Y., and Kauer J.A. High-frequency afferent stimulation induces long-term potentiation of field potentials in the ventral tegmental area. Neuropsychopharmacology 33 (2008) 1704-1712
30. Pacak K., Armando I., Komoly S., Fukuhara K., Weise V.K., Holmes C., et al. Hypercortisolemia inhibits YOH-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats. Endocrinology 131 (1992) 1369-1376
31. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
32. Piercey M.F., Smith M.W., and Lum-Ragan J.T. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties. J Pharmacol Exp Ther 268 (1994) 1297-1303
33. Rickels K. Buspirone in clinical practice. J Clin Psychiatry 51 Suppl. (1990) 51-54
34. Salchner P., and Singewald N. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology 43 (2002) 1238-1248
35. Shaham V., Highfield D., Delfs J.M., Leung S., and Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of the LC NAergic neurons. Eur J Neurosci 12 (2000) 292-302
36. Shepard J.D., Bossert J.M., Liu S.Y., and Shaham Y. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55 (2004) 1082-1089
37. Stamford J., Crespi F., and Marsden C.A. In vivo voltammetric methods for monitoring monoamine release and metabolism. Practical approach series monitoring neuronal activity (1992), Irl Press at Oxford University Press, Oxford, UK p. 113-145
38. Stine S.M., Grillon G.C., Morgan C.A., and Crystal J.H. Methadone patients exhibit increased startle and cortisol response after YOH iv. Psychopharmacology 154 (2001) 274-281
39. Stine S.M., Southwicks S.M., Petrakis I.L., and Crystal J.H. YOH-induced withdrawal and anxiety symptoms in opioid dependent patients. Biol Psychiatry 51 (2002) 642-651
40. Tanaka M., Yoshida M., Emoto H., and Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 405 1-3 (2000) 397-406
41. Van Loon G.R., Kvetnansky R., McCarty R., and Axelrod J. Stress, neurochemical and humoral mechanisms (1989), Gordon & Breach Science Publishers S.A., New York
42. Wang X., Cen X., and Lu L. Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol m432 (2001) 153-161